WHO Drug Information
Volume 21, Number 2, 2007
This issue of WHO DRUG INFORMATION provides readers with the complete WHO Model List of Essential Medicines agreed during the Expert Committee meeting held in Geneva in March 2007.
Activities involving neglected tropical diseases are gaining in strength and number, while an open access database has recently been established to facilitate research involving new product development.
The section on Safety and Efficacy gives the latest information on signals and reports of adverse reactions, with other news from around the world, including labeling changes and alerts. This is complemented by Regulatory Action and News which provides the most recent decisions from regulatory authorities, and particularly those having an impact on decision-taking.
International Pharmacopoeia monographs for pharmaceuticals included in the WHO Model List continue to be developed and the latest drafts on artemether/lumefantrine, magnesium sulfate, and paediatric zinc sulfate are proposed for comment.
Finally, many interesting publications and activities are reviewed and the journal concludes with the latest list of Proposed International Nonproprietary Names (INN).